Arsalan Khalid

Arsalan Khalid is a Senior Scientist in the Manufacturing Science & Technology (MSAT) team at Vertex Pharmaceuticals, specializing in the commercialization of CRISPR-CAS9 gene-edited cell therapy for sickle cell disease and beta thalassemia. Previous roles include a Scientist at DynamiCure Biotechnology, where Arsalan led downstream purification of antibody candidates, and a Process Engineer at Solid Biosciences, focusing on technology transfer and scale-up for AAV production. Additional experience spans positions at Shyne Labs, Precision Plant Molecules, and a brief internship with Meta Materials Inc., all emphasizing process development and engineering in various biotechnology applications. Arsalan's academic credentials include two Master's degrees in Environmental and Chemical Engineering and a Bachelor's degree in Chemical and Process Engineering.